-
1
-
-
84866596020
-
ESMO clinical practice guidelines for diagnosis, treatment and follow-up
-
Soft tissue and visceral sarcoma. ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2012; 23(suppl 7): 92-99.
-
(2012)
Annals of Oncology
, vol.23
, pp. 92-99
-
-
-
2
-
-
80155150199
-
Sarcomas of the soft tissue and bone
-
Devita VT, Lawrence TS, Rosenberg SA (eds), 8th edition. Philadelphia: Lippincott Williams and Wilkins
-
Brennan MF, Singer S, Maki R et al. Sarcomas of the soft tissue and bone. In Devita VT, Lawrence TS, Rosenberg SA (eds). Cancer Principles and Practice of Oncology, 8th edition. Philadelphia: Lippincott Williams and Wilkins 2008; 1741-1794.
-
(2008)
Cancer Principles and Practice of Oncology
, pp. 1741-1794
-
-
Brennan, M.F.1
Singer, S.2
Maki, R.3
-
3
-
-
77649144152
-
Extremity soft tissue sarcoma in a series of patients treated at a single institution
-
Gronchi A, Lo Vullo S, Colombo C et al. Extremity soft tissue sarcoma in a series of patients treated at a single institution. Ann Surg 2010; 251: 512-517.
-
(2010)
Ann Surg
, vol.251
, pp. 512-517
-
-
Gronchi, A.1
Lo Vullo, S.2
Colombo, C.3
-
4
-
-
58149353006
-
Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control
-
Bonvalot S, Rivoire M, Castaing M et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol 2009; 27(1): 31-37.
-
(2009)
J Clin Oncol
, vol.27
, Issue.1
, pp. 31-37
-
-
Bonvalot, S.1
Rivoire, M.2
Castaing, M.3
-
6
-
-
0037216150
-
Advanced soft tissue sarcoma: a disease that a potentially curable subset of patients treated with chemotherapy
-
Blay JY, Van Glabbeke M, Verweij J et al. Advanced soft tissue sarcoma: a disease that a potentially curable subset of patients treated with chemotherapy. Eur J Cancer 2003; 39: 64-69.
-
(2003)
Eur J Cancer
, vol.39
, pp. 64-69
-
-
Blay, J.Y.1
Van Glabbeke, M.2
Verweij, J.3
-
7
-
-
0031566814
-
Sarcoma Meta-Analysis Collaboration
-
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-Analysis Collaboration. Lancet 1997; 350: 1647-1654.
-
(1997)
Lancet
, vol.350
, pp. 1647-1654
-
-
-
8
-
-
0000862573
-
A systematic overview and quantitative metaanalysis
-
Jones GW, Chouinard M, Patel M. A systematic overview and quantitative metaanalysis. Clin Invest Med 1991; 14(suppl 19): A772.
-
(1991)
Clin Invest Med
, vol.14
-
-
Jones, G.W.1
Chouinard, M.2
Patel, M.3
-
9
-
-
0002611831
-
Defining the role of adjuvant chemotherapy for patients with soft tissue sarcoma of the extremities
-
Salmon SE (ed). Philadelphia: JB Lippincott
-
Zalupski MM, Ryan JR, Hussein ME et al. Defining the role of adjuvant chemotherapy for patients with soft tissue sarcoma of the extremities. In Salmon SE (ed). Adjuvant Therapy of Cancer VII. Philadelphia: JB Lippincott 1993; 385-392.
-
(1993)
Adjuvant Therapy of Cancer VII
, pp. 385-392
-
-
Zalupski, M.M.1
Ryan, J.R.2
Hussein, M.E.3
-
10
-
-
0029087491
-
Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials
-
Tierney JF, Mosseri V, Stewart LA et al. Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials. Br J Cancer 1995; 72: 469-475.
-
(1995)
Br J Cancer
, vol.72
, pp. 469-475
-
-
Tierney, J.F.1
Mosseri, V.2
Stewart, L.A.3
-
11
-
-
0035282058
-
Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian Randomised Cooperative Trial
-
Frustaci S, Gherlinzoni F, De Paoli A et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian Randomised Cooperative Trial. J Clin Oncol 2001; 19: 1238-1247.
-
(2001)
J Clin Oncol
, vol.19
, pp. 1238-1247
-
-
Frustaci, S.1
Gherlinzoni, F.2
De Paoli, A.3
-
12
-
-
16544363434
-
Cohort analysis of patients with localized, highrisk, extremity soft-tissue sarcoma treated at two cancer centers: chemotherapyassociated outcomes
-
Cormier JN, Huang X, Xing Y et al. Cohort analysis of patients with localized, highrisk, extremity soft-tissue sarcoma treated at two cancer centers: chemotherapyassociated outcomes. J Clin Oncol 2004; 22: 4567-4574.
-
(2004)
J Clin Oncol
, vol.22
, pp. 4567-4574
-
-
Cormier, J.N.1
Huang, X.2
Xing, Y.3
-
13
-
-
0034527930
-
Intensified adjuvant IFADIC chemotherapy for adult soft tissue sarcoma: a prospective randomized feasibility trial
-
Brodowicz T, Schwameis E, Widder J et al. Intensified adjuvant IFADIC chemotherapy for adult soft tissue sarcoma: a prospective randomized feasibility trial. Sarcoma 2000; 4: 151-160.
-
(2000)
Sarcoma
, vol.4
, pp. 151-160
-
-
Brodowicz, T.1
Schwameis, E.2
Widder, J.3
-
14
-
-
0036793736
-
Adjuvant epirubicin with or without ifosfamide for adult soft-tissue sarcoma
-
Petrioli R, Coratti A, Correale P et al. Adjuvant epirubicin with or without ifosfamide for adult soft-tissue sarcoma. Am J Clin Oncol 2002, 25(5): 468-473.
-
(2002)
Am J Clin Oncol
, vol.25
, Issue.5
, pp. 468-473
-
-
Petrioli, R.1
Coratti, A.2
Correale, P.3
-
15
-
-
84984909046
-
Adjuvant chemotherapy with doxorubicin, ifosfamide and lenograstim for resected soft tissue sarcoma
-
Woll PJ, Reicheardt P, Le Cesne A et al. Adjuvant chemotherapy with doxorubicin, ifosfamide and lenograstim for resected soft tissue sarcoma. Lancet Oncol 2012; 12: 1470.
-
(2012)
Lancet Oncol
, vol.12
, pp. 1470
-
-
Woll, P.J.1
Reicheardt, P.2
Le Cesne, A.3
-
16
-
-
49049089340
-
A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma
-
Pervaiz N, Colterjohn N, Farrokhyar F et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 2008; 113: 573-581.
-
(2008)
Cancer
, vol.113
, pp. 573-581
-
-
Pervaiz, N.1
Colterjohn, N.2
Farrokhyar, F.3
-
17
-
-
0028334634
-
Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma-reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
-
Bramwell V, Rouesse J, Steward W. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma-reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1994; 12: 1137-1149.
-
(1994)
J Clin Oncol
, vol.12
, pp. 1137-1149
-
-
Bramwell, V.1
Rouesse, J.2
Steward, W.3
-
18
-
-
33750492907
-
Function preserving surgery of limb sarcomas: history and improvements
-
Bonvalot S, Missana MC, Le Cesne A et al. Function preserving surgery of limb sarcomas: history and improvements. Cancer Radiother 2006; 10(6-7): 416-424.
-
(2006)
Cancer Radiother
, vol.10
, Issue.6-7
, pp. 416-424
-
-
Bonvalot, S.1
Missana, M.C.2
Le Cesne, A.3
-
19
-
-
84867402175
-
Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG
-
Bonvalot S, Raut CP, Pollock RE et al. Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG. Ann Surg Oncol 2012; 19(9): 2981-2991.
-
(2012)
Ann Surg Oncol
, vol.19
, Issue.9
, pp. 2981-2991
-
-
Bonvalot, S.1
Raut, C.P.2
Pollock, R.E.3
-
20
-
-
0029913782
-
Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities
-
Pisters PW, Leung DH, Woodruff J et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996; 14: 1679-1689.
-
(1996)
J Clin Oncol
, vol.14
, pp. 1679-1689
-
-
Pisters, P.W.1
Leung, D.H.2
Woodruff, J.3
-
21
-
-
0035873187
-
Predictive value of grade for metastasis development in the main histological types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group
-
Coindre JM, Terrier P, Guillou L et al. Predictive value of grade for metastasis development in the main histological types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 2001; 91: 1914-1926.
-
(2001)
Cancer
, vol.91
, pp. 1914-1926
-
-
Coindre, J.M.1
Terrier, P.2
Guillou, L.3
-
22
-
-
0032952928
-
Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracyclin-containing first-line regimens-a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study
-
Van Glabekke M, van Oosterom AT, Oosterhuis JW et al. Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracyclin-containing first-line regimens-a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol 1999; 17: 150-157.
-
(1999)
J Clin Oncol
, vol.17
, pp. 150-157
-
-
Van Glabekke, M.1
van Oosterom, A.T.2
Oosterhuis, J.W.3
-
23
-
-
78649491471
-
Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database
-
Italiano A, Delva F, Mathoulin-Pelissier S et al. Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database. Ann Oncol 2010; 21(12): 2436-2441.
-
(2010)
Ann Oncol
, vol.21
, Issue.12
, pp. 2436-2441
-
-
Italiano, A.1
Delva, F.2
Mathoulin-Pelissier, S.3
-
24
-
-
62849096370
-
Adjuvant imatinib mesylate after resection of localized, primary gastrointestinal stromal tumour: a randomized, double-blind, placebo-controlled trial
-
De Matteo RP, Ballman KV, Antonescu CR et al. Adjuvant imatinib mesylate after resection of localized, primary gastrointestinal stromal tumour: a randomized, double-blind, placebo-controlled trial. Lancet 2009; 373(9669): 1097-1104.
-
(2009)
Lancet
, vol.373
, Issue.9669
, pp. 1097-1104
-
-
De Matteo, R.P.1
Ballman, K.V.2
Antonescu, C.R.3
-
25
-
-
84859187987
-
One versus three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial
-
Joensuu H, Eriksson M, Sundby Hall K et al. One versus three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA 2012; 307(12): 1265-1272.
-
(2012)
JAMA
, vol.307
, Issue.12
, pp. 1265-1272
-
-
Joensuu, H.1
Eriksson, M.2
Sundby Hall, K.3
-
26
-
-
84879968987
-
Adhesion to clinical practices guidelines (CPG's) and role on survival for tissue sarcoma patients. Analysis of a population based cohort from Rhone-Alpes region
-
Derbel O, Cropet C, Meeus P et al. Adhesion to clinical practices guidelines (CPG's) and role on survival for tissue sarcoma patients. Analysis of a population based cohort from Rhone-Alpes region. Ann Oncol 2012; 23(suppl 9): 478-491.
-
(2012)
Ann Oncol
, vol.23
, pp. 478-491
-
-
Derbel, O.1
Cropet, C.2
Meeus, P.3
-
27
-
-
84906332168
-
Prospective web-based collection of sarcoma cases diagnosed and treated in France: experience of the NetSarc network of the French Sarcoma Tumor Boards
-
Ducimetière F, Blay JY, Le Cesne A et al. Prospective web-based collection of sarcoma cases diagnosed and treated in France: experience of the NetSarc network of the French Sarcoma Tumor Boards. J Clin Oncol 2012; 30(suppl); abstr 10056.
-
(2012)
J Clin Oncol
, vol.30
-
-
Ducimetière, F.1
Blay, J.Y.2
Le Cesne, A.3
-
28
-
-
84875466344
-
Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas
-
Lagarde P, Przybyl J, Brulard C et al. Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas. J Clin Oncol 2013; 31: 1-9.
-
(2013)
J Clin Oncol
, vol.31
, pp. 1-9
-
-
Lagarde, P.1
Przybyl, J.2
Brulard, C.3
-
29
-
-
73349100029
-
Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven adjuvant CT
-
Blay JY, Le Cesne A. Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven adjuvant CT. Oncologist 2009; 14: 1013-1020.
-
(2009)
Oncologist
, vol.14
, pp. 1013-1020
-
-
Blay, J.Y.1
Le Cesne, A.2
-
30
-
-
77954535843
-
Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity
-
Chibon F, Lagarde P, Salas S et al. Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity. Nat Med 2010; 16(7): 781-788.
-
(2010)
Nat Med
, vol.16
, Issue.7
, pp. 781-788
-
-
Chibon, F.1
Lagarde, P.2
Salas, S.3
-
31
-
-
79957579501
-
Topoisomerase II-alpha protein expression and histological response following doxorubicin-based induction chemotherapy predict survival of locally advanced soft tissue sarcoma
-
Ruiz-Soto R, Auger N, Tournay E et al. Topoisomerase II-alpha protein expression and histological response following doxorubicin-based induction chemotherapy predict survival of locally advanced soft tissue sarcoma. Eur J Cancer 2011; 47: 1319-1327.
-
(2011)
Eur J Cancer
, vol.47
, pp. 1319-1327
-
-
Ruiz-Soto, R.1
Auger, N.2
Tournay, E.3
-
32
-
-
20844433223
-
Progression-free survival in gastrointestinal stromal tumours with high dose imatinib: randomized trial
-
Verweij J, Casali GP et al. Progression-free survival in gastrointestinal stromal tumours with high dose imatinib: randomized trial. Lancet 2004; 364: 1127-1134.
-
(2004)
Lancet
, vol.364
, pp. 1127-1134
-
-
Verweij, J.1
Casali, G.P.2
-
33
-
-
77950469922
-
Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials
-
Rutkowski P, Van Glabbeke M, Rankin CJ et al. Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials. J Clin Oncol 2010; 28(10): 1772-1778.
-
(2010)
J Clin Oncol
, vol.28
, Issue.10
, pp. 1772-1778
-
-
Rutkowski, P.1
Van Glabbeke, M.2
Rankin, C.J.3
-
34
-
-
77349120482
-
Denosumab in patients with giant-cell tumor of bone: a open-label phase II
-
Thomas D, Henshaw R, Skubitz K et al. Denosumab in patients with giant-cell tumor of bone: a open-label phase II. Lancet Oncol 2010; 11: 275-280.
-
(2010)
Lancet Oncol
, vol.11
, pp. 275-280
-
-
Thomas, D.1
Henshaw, R.2
Skubitz, K.3
-
35
-
-
84857530639
-
Phase II clinical trial of neo-adjuvant trabectedin in patients with advanced localized myxoid liposarcoma
-
Gronchi A, Bui NB, Bonvalot S et al. Phase II clinical trial of neo-adjuvant trabectedin in patients with advanced localized myxoid liposarcoma. Ann Oncol 2012; 23: 771-776.
-
(2012)
Ann Oncol
, vol.23
, pp. 771-776
-
-
Gronchi, A.1
Bui, N.B.2
Bonvalot, S.3
-
36
-
-
84882955940
-
Cediranib for metastatic alveolar soft part sarcoma
-
Kummar S, Allen D, Monks A et al. Cediranib for metastatic alveolar soft part sarcoma. J Clin Oncol 2013; 18: 2296-2302.
-
(2013)
J Clin Oncol
, vol.18
, pp. 2296-2302
-
-
Kummar, S.1
Allen, D.2
Monks, A.3
-
37
-
-
84861098484
-
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double blind, placebo-controlled phase III trial
-
Van Der Graaf WTA, Blay JY, Chawla SP et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double blind, placebo-controlled phase III trial. Lancet Oncol 2012; 379: 1879-1886.
-
(2012)
Lancet Oncol
, vol.379
, pp. 1879-1886
-
-
Van Der Graaf, W.T.A.1
Blay, J.Y.2
Chawla, S.P.3
|